A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain
Clinical trial NCT06076486 · COMPLETED
Trial details
- NCT number
- NCT06076486
- Sponsor
- Nanjing Chia-tai Tianqing Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-14
- Primary completion
- 2024-11-22
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.